- Revenue increased 28.1% year over year to $47.0 million,
exceeding original guidance
- Adjusted gross margin increased to 13.5%
- Achieved record backlog of $486.7 million
Microvast Holdings, Inc. (NASDAQ:MVST) (“Microvast” or the
“Company”), a technology innovator that designs, develops and
manufactures lithium-ion battery solutions, today announced
unaudited condensed consolidated financial results for the first
quarter ended March 31, 2023 (“Q1 2023”).
“In the first quarter, we delivered stronger than anticipated
year-over-year revenue growth, led by the initial production ramp
up of several of our commercial vehicle customers in Europe” said
Yang Wu, Microvast’s Founder, Chairman, President and Chief
Executive Officer. “We are very pleased to have completed our
expansion and have begun trial production in Huzhou, China which
adds 2GWh of production capacity for our new 53.5Ah cell. In
addition, our Clarksville, Tennessee facility remains on track for
start of production in the fourth quarter, bringing our total
53.5Ah capacity additions this year to 4GWh. Customer adoption of
our new cell is very strong and over 50% of our new capacity in
Huzhou is already under contract.”
"We are pleased to report another quarter of solid growth with
improving gross margins and another record backlog of $486.7
million, which really underpins our revenue plan for this year, and
gives us the conviction to raise our guidance,” said Craig Webster,
Microvast’s Chief Financial Officer. “We are very encouraged by the
level of customer engagement and interest in our Clarksville plant,
which along with anticipated IRA credits, is providing multiple
project finance opportunities.”
Results for Q1 2023
- Revenue of $47.0 million, compared to $36.7 million in Q1 2022,
an increase of 28.1%
- Gross margin increased to 10.3% from gross margin of 0% in Q1
2022; Non-GAAP adjusted gross margin increased to 13.5%, up from
5.2% in Q1 2022
- Operating expenses of $36.2 million, compared to $43.4 million
in Q1 2022; Adjusted operating expenses of $19.8 million, compared
to $31.1 million in Q1 2022
- Net loss of $29.6 million, compared to net loss of $43.8
million in Q1 2022; Non-GAAP adjusted net loss of $11.7 million,
compared to non-GAAP adjusted net loss of $29.1 million in Q1
2022
- Net loss per share of $0.10 compared to net loss per share of
$0.15 in Q1 2022; Non-GAAP adjusted net loss per share of $0.04,
compared to non-GAAP adjusted net loss per share of $0.10 in Q1
2022
- Adjusted EBITDA of $(7.5) million in Q1 2023, compared to
Adjusted EBITDA of $(23.1) million in Q1 2022
- Backlog as of March 31, 2023 was $486.7 million, representing
growth of 302.9% compared to $120.8 million in backlog as of March
31, 2022 and sequential growth of 18.6% compared to $410.5 million
in backlog at December 31, 2022.
- Capital expenditures of $35.9 million, compared to $41.1
million in Q1 2022, and were driven by investments in manufacturing
capacity expansions in Huzhou, China and Clarksville,
Tennessee
- Cash, cash equivalents, restricted cash and short-term
investments equalled $285.8 million as of March 31, 2023, compared
to $327.7 million as of December 31, 2022 and $470.7 million as of
March 31, 2022
Please refer to the tables at the end of this press release for
reconciliations of gross profit to non-GAAP adjusted gross profit,
and net loss to non-GAAP adjusted net loss and non-GAAP adjusted
EBITDA.
2023 Outlook
- Due to a stronger than expected Q1 2023 performance and
underpinned by a record backlog of $486.7 million, the company is
raising its full year 2023 revenue guidance to a range of $348
million and $368 million, reflecting year over year growth of 70%
to 80%, up from 65% to 75% previously.
- For Q2 2023, the company expects revenue to be in the range of
$63 million to $67 million.
- Deliveries of new 53.5Ah cell starting in second quarter from
new cell, module and pack line in Huzhou, China and in fourth
quarter from Clarksville, Tennessee
- Capital expenditures for the full year are anticipated to be in
the range of $180.0 million to $210.0 million
Webcast Information
Company management will host a conference call and webcast to
discuss the Company’s financial results on May 9, 2023, at 5:00
p.m. Central Time, to discuss the Company's financial results. The
live webcast and accompanying slide presentation will be accessible
from the Events & Presentations section of Microvast’s investor
relations website
(https://ir.microvast.com/events-presentations/events). A replay
will be available following the conclusion of the event. Investment
community professionals interested in participating in the Q&A
session may join the call by dialing +1 (631) 891-4304.
About Microvast
Founded in 2006 as a research and technology driven company,
Microvast has evolved into a global technology leader in the
design, development and manufacture of battery solutions for mobile
and stationary applications.
Since placing its first battery systems into operation in
electric buses more than a decade ago, Microvast has expanded its
business to serve a broad range of commercial, passenger and
specialty vehicles, including mining, material handling, and power
vehicles and equipment, as well as grid-scale energy storage
applications.
Microvast is renowned for its cutting-edge cell technology and
its vertical integration capabilities which extend from core
battery chemistry (cathode, anode, electrolyte, and separator) to
modules and packs. By integrating the process from raw material to
system assembly, Microvast has developed a family of products
covering a breadth of market applications, including electric
vehicles, energy storage and battery components. Microvast is
headquartered in Stafford, Texas. For more information, please
visit www.microvast.com or follow us on LinkedIn or Twitter
(@microvast).
Cautionary Statement Regarding Forward-Looking
Statements
This communication contains “forward-looking statements” within
the meaning of the Private Securities Litigation Reform Act of
1995. Such statements include, but are not limited to, statements
about future financial and operating results, our objectives,
expectations and intentions with respect to future operations,
products and services; and other statements identified by words
such as “anticipate,” “believe,” “continue,” “could,” “estimate,”
“expect,” “intend,” “may,” “might,” “objective,” “plan,” “project,”
“predict,” “outlook” “should,” “will,” “would,” or the negative of
these terms, or other comparable terminology intended to identify
statements about the future. These forward-looking statements
include, but are not limited to, statements regarding our industry
and market sizes, and future opportunities for us. Such
forward-looking statements are based upon the current beliefs and
expectations of management and are inherently subject to
significant business, economic and competitive uncertainties and
contingencies, many of which are difficult to predict and generally
beyond our control. Actual results and the timing of events may
differ materially from the results anticipated in these
forward-looking statements.
Many factors could cause actual results and the timing of events
to differ materially from the anticipated results or other
expectations expressed in the forward-looking statements,
including, among others: (1) changes in the highly competitive
market in which we compete, including with respect to our
competitive landscape, technology evolution or regulatory changes;
(2) risk that we may not be able to execute our growth strategies
or achieve profitability; (3) risks of operations in China; (4) the
impact of inflation; (5) changes in availability and price of raw
materials; (6) changes in the markets that we target; (7)
heightened awareness of environmental issues and concern about
global warming and climate change; (8) risk that we are unable to
secure or protect our intellectual property; (9) risk that our
customers or third-party suppliers are unable to meet their
obligations fully or in a timely manner; (10) risk that our
customers will adjust, cancel or suspend their orders for our
products; (11) risk that we will need to raise additional capital
to execute our business plan, which may not be available on
acceptable terms or at all; (12) risk of product liability or
regulatory lawsuits or proceedings relating to our products or
services; (13) economic, financial and other impacts of the
coronavirus (“COVID-19”) pandemic, including global supply chain
disruptions; and (14) the conflict between Russia and Ukraine and
any restrictive actions that have been or may be taken by the U.S.
and/or other countries in response thereto, such as sanctions or
export controls. Microvast’s annual, quarterly and other filings
with the U.S. Securities and Exchange Commission identify, address
and discuss these and other factors in the sections entitled “Risk
Factors.”
Actual results, performance or achievements may differ
materially, and potentially adversely, from any forward-looking
statements and the assumptions on which those forward-looking
statements are based. There can be no assurance that the data
contained herein is reflective of future performance to any degree.
You are cautioned not to place undue reliance on forward-looking
statements as a predictor of future performance as forward-looking
statements are based on estimates and assumptions that are
inherently subject to various significant risks, uncertainties and
other factors, many of which are beyond our control. All
information set forth herein speaks only as of the date hereof, and
we disclaim any intention or obligation to update any
forward-looking statements as a result of developments occurring
after the date hereof except as may be required under applicable
securities laws. Forecasts and estimates regarding our industry and
end markets are based on sources we believe to be reliable,
however, there can be no assurance these forecasts and estimates
will prove accurate in whole or in part.
Non-GAAP Financial Measures
To provide investors with additional information regarding our
financial results, Microvast has disclosed in this earnings release
non-GAAP financial measures, including non-GAAP adjusted gross
profit (loss), non-GAAP adjusted EBITDA and non-GAAP adjusted net
loss, which are non-GAAP financial measures as defined under the
rules of the SEC. These are intended as supplemental measures of
our financial performance that are not required by, or presented in
accordance with U.S. generally accepted accounting principles
(“GAAP”).
Reconciliations to the most comparable GAAP measures, gross
profit and net income (loss), are contained in tabular form in the
unaudited financial statements below. Non-GAAP adjusted gross
profit is GAAP gross profit as adjusted for non-cash stock-based
compensation expense included in cost of revenues. Non-GAAP
adjusted net loss is GAAP net loss as adjusted for non-cash
stock-based compensation expense and change in valuation of warrant
liabilities. Non-GAAP adjusted net loss per common share is GAAP
net loss per common share as adjusted for non-cash stock-based
compensation expense and change in valuation of warrant liabilities
per common share. Non-GAAP adjusted EBITDA is defined as net loss
excluding depreciation and amortization, non-cash settled
share-based compensation expense, interest expense, interest
income, changes in fair value of our warrant liability and income
tax expense or benefit.
We use non-GAAP adjusted gross profit, non-GAAP adjusted EBITDA
and non-GAAP adjusted net loss for financial and operational
decision-making and as a means to evaluate period-to-period
comparisons. We consider them to be important measures because they
help illustrate underlying trends in our business and our
historical operating performance on a more consistent basis. We
believe that these non-GAAP financial measures, when taken together
with their most directly comparable GAAP measures, gross profit and
net income (loss), provide meaningful supplemental information
regarding our performance by excluding certain items that may not
be indicative of our recurring core business operating results.
We believe that both management and investors benefit from
referring to these non-GAAP financial measures in assessing our
performance and when planning, forecasting, and analyzing future
periods. These non-GAAP financial measures also facilitate
management’s internal comparisons to our historical performance. We
believe these non-GAAP financial measures are useful to investors
both because (1) they allow for greater transparency with respect
to key metrics used by management in its financial and operational
decision-making and (2) they are used by our institutional
investors and the analyst community to help them analyze the health
of our business. Accordingly, we believe that these non-GAAP
financial measures provide useful information to investors and
others in understanding and evaluating our operating results in the
same manner as our management team and board of directors.
Non-GAAP financial measures have limitations as an analytical
tool, and you should not consider them in isolation, or as a
substitute for, financial information prepared in accordance with
GAAP. For example, our calculation of non-GAAP adjusted EBITDA may
differ from similarly titled non-GAAP measures, if any, reported by
our peer companies, or our peer companies may use other measures to
calculate their financial performance, and therefore our use of
non-GAAP adjusted EBITDA may not be directly comparable to
similarly titled measures of other companies. The principal
limitation of non-GAAP adjusted EBITDA is that it excludes
significant expenses and income that are required by GAAP to be
recorded in our financial statements. In addition, it is subject to
inherent limitations as it reflects the exercise of judgments by
management about which expense and income are excluded or included
in determining this non-GAAP financial measure. In order to
compensate for these limitations, management presents non-GAAP
financial measures in connection with GAAP results. In addition,
such financial information is unaudited and does not conform to SEC
Regulation S-X and as a result, such information may be presented
differently in our future filings with the SEC. For example, with
respect to the warrant liability resulting from the merger, we now
exclude changes in fair value from net loss in our non-GAAP
adjusted EBITDA and non-GAAP adjusted net loss calculation, which
had not been done in prior periods.
MICROVAST HOLDINGS,
INC.
UNAUDITED CONDENSED
CONSOLIDATED BALANCE SHEETS
(In thousands of U.S. dollars,
except share and per share data, or as otherwise noted)
December 31,
2022
March 31, 2023
Assets
Current assets:
Cash and cash equivalents
$
231,420
$
200,305
Restricted cash, current
70,732
60,164
Short-term investments
25,070
25,313
Accounts receivable (net of allowance for
credit losses of $4,407 and $3,270 as of December 31, 2022 and
March 31, 2023, respectively)
119,304
88,911
Notes receivable
2,196
21,202
Inventories, net
84,252
87,669
Prepaid expenses and other current
assets
12,093
13,472
Total Current Assets
545,067
497,036
Restricted cash, non-current
465
11
Property, plant and equipment, net
335,140
443,051
Land use rights, net
12,639
12,618
Acquired intangible assets, net
1,636
3,691
Operating lease right-of-use assets
16,368
18,461
Other non-current assets
73,642
29,113
Total Assets
$
984,957
$
1,003,981
Liabilities
Current liabilities:
Accounts payable
$
44,985
$
41,243
Advance from customers
54,207
53,059
Accrued expenses and other current
liabilities
66,720
93,147
Income tax payables
658
658
Short-term bank borrowings
17,398
21,842
Notes payable
68,441
67,804
Total Current Liabilities
252,409
277,753
Long-term bonds payable
43,888
43,888
Long-term bank borrowings
28,997
29,122
Warrant liability
126
109
Share-based compensation liability
131
138
Operating lease liabilities
14,347
15,825
Other non-current liabilities
32,082
31,317
Total Liabilities
$
371,980
$
398,152
Shareholders’ Equity
Common Stock (par value of US$0.0001 per
share, 750,000,000 and 750,000,000 shares authorized as of December
31, 2022 and March 31, 2023; 309,316,011 and 309,427,448 shares
issued, and 307,628,511 and 307,739,948 shares outstanding as of
December 31, 2022 and March 31, 2023)
$
31
$
31
Additional paid-in capital
1,416,160
1,434,221
Statutory reserves
6,032
6,032
Accumulated deficit
(791,165
)
(820,746
)
Accumulated other comprehensive loss
(18,081
)
(15,861
)
Total Microvast Holding, Inc.
shareholders’ equity
612,977
603,677
Noncontrolling interests
$
—
$
2,152
Total Equity
$
612,977
$
605,829
Total Liabilities and Equity
$
984,957
$
1,003,981
MICROVAST HOLDINGS,
INC.
UNAUDITED CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands of U.S. dollars,
except share and per share data, or as otherwise noted)
Three Months Ended
March 31,
2022
2023
Revenues
$
36,668
$
46,973
Cost of revenues
(36,655
)
(42,115
)
Gross profit
13
4,858
Operating expenses:
General and administrative expenses
(26,101
)
(20,385
)
Research and development expenses
(11,309
)
(10,861
)
Selling and marketing expenses
(5,998
)
(4,988
)
Total operating expenses
(43,408
)
(36,234
)
Subsidy income
137
77
Loss from operations
(43,258
)
(31,299
)
Other income and expenses:
Interest income
314
1,381
Interest expense
(796
)
(459
)
Changes in fair value of warrant
liability
(435
)
17
Other income, net
399
789
Loss before provision for income
taxes
(43,776
)
(29,571
)
Income tax expense
—
—
Net loss
$
(43,776
)
$
(29,571
)
Less: net income attributable to
noncontrolling interests
—
10
Net loss attributable to Microvast
Holdings, Inc.'s shareholders
$
(43,776
)
$
(29,581
)
Net loss per common share
Basic and diluted
$
(0.15
)
$
(0.10
)
Weighted average shares used in
calculating net loss per share of common stock
Basic and diluted
298,843,016
307,714,841
MICROVAST HOLDINGS,
INC.
UNAUDITED CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands of U.S. dollars,
except share and per share data, or as otherwise noted)
Three Months Ended
March 31,
2022
2023
Cash flows from operating activities
Net loss
$
(43,776
)
$
(29,571
)
Adjustments to reconcile net loss to net
cash used in operating activities:
Loss on disposal of property, plant and
equipment
12
824
Depreciation of property, plant and
equipment
5,310
4,892
Amortization of land use right and
intangible assets
143
205
Noncash lease expenses
557
658
Share-based compensation
28,130
17,929
Changes in fair value of warrant
liability
435
(17
)
Reversal of credit losses
(545
)
(1,094
)
Provision for obsolete inventories
471
—
Impairment loss from property, plant and
equipment
6
—
Product warranty
2,685
2,530
Changes in operating assets and
liabilities:
Notes receivable
(13,468
)
(21,340
)
Accounts receivable
8,746
32,293
Inventories
(4,878
)
(7,039
)
Prepaid expenses and other current
assets
(2,586
)
(857
)
Amounts due from/to related parties
85
—
Operating lease right-of-use assets
(18,945
)
(2,493
)
Other non-current assets
(51
)
288
Notes payable
9,391
(936
)
Accounts payable
(8,605
)
(3,956
)
Advance from customers
2,063
(1,179
)
Accrued expenses and other liabilities
(6,165
)
(3,434
)
Operating lease liabilities
16,146
1,239
Other non-current liabilities
(75
)
(108
)
Net cash used in operating
activities
(24,914
)
(11,166
)
Cash flows from investing activities
Purchases of property, plant and
equipment
(41,061
)
(35,922
)
Proceeds on disposal of property, plant
and equipment
1
340
Purchase of short-term investments
—
(243
)
Net cash used in investing
activities
(41,060
)
(35,825
)
Cash flows from financing activities
Proceeds from borrowings
—
4,384
Repayment of bank borrowings
—
—
Net cash generated from financing
activities
—
4,384
Effect of exchange rate changes
598
470
Decrease in cash, cash equivalents and
restricted cash
(65,376
)
(42,137
)
Cash, cash equivalents and restricted
cash at beginning of the period
536,109
302,617
Cash, cash equivalents and restricted
cash at end of the period
$
470,733
$
260,480
MICROVAST HOLDINGS,
INC.
UNAUDITED CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS-Continued
(In thousands of U.S. dollars,
except share and per share data, or as otherwise noted)
Three Months Ended
March 31,
2022
2023
Reconciliation to amounts on consolidated
balance sheets
Cash and cash equivalents
$
416,165
$
200,305
Restricted cash
54,568
60,175
Total cash, cash equivalents and
restricted cash
$
470,733
$
260,480
MICROVAST HOLDINGS,
INC.
RECONCILIATION OF GROSS PROFIT
TO ADJUSTED GROSS PROFIT
(Unaudited, in thousands of
U.S. dollars)
Three Months Ended
March 31,
2022
2023
Revenues
$
36,668
$
46,973
Cost of revenues
(36,655
)
(42,115
)
Gross profit (GAAP)
$
13
$
4,858
Gross margin
—
%
10.3
%
Non-cash settled share-based compensation
(included in cost of revenues)
1,899
1,504
Adjusted gross profit
(non-GAAP)
$
1,912
$
6,362
Adjusted gross margin (non-GAAP)
5.2
%
13.5
%
MICROVAST HOLDINGS,
INC.
RECONCILIATION OF NET LOSS TO
ADJUSTED NET LOSS
(In thousands of U.S. dollars,
except per share data, or as otherwise noted)
Three Months Ended
March 31,
2022
2023
Net loss (GAAP)
$
(43,776
)
$
(29,571
)
Changes in fair value of warrant
liability
435
(17
)
Non-cash settled share-based
compensation
14,257
17,921
Adjusted Net Loss (non-GAAP)
$
(29,084
)
$
(11,667
)
Three Months Ended
March 31,
2022
2023
Net loss per common share-Basic and
diluted (GAAP)
$
(0.15
)
$
(0.10
)
Changes in fair value of warranty
liability per common share
—
—
Non-cash settled share-based compensation
per common share
0.05
0.06
Adjusted net loss per common
share-Basic and diluted (non-GAAP)
$
(0.10
)
$
(0.04
)
MICROVAST HOLDINGS,
INC.
RECONCILIATION OF NET LOSS TO
EBITDA AND ADJUSTED EBITDA
(Unaudited, in thousands of
U.S. dollars)
Three Months Ended
March 31,
2022
2023
Net loss (GAAP)
$
(43,776
)
$
(29,571
)
Interest expense (income), net
482
(922
)
Income tax expense
—
—
Depreciation and amortization
5,453
5,097
EBITDA (non-GAAP)
$
(37,841
)
$
(25,396
)
Changes in fair value of warrant
liability
435
(17
)
Non-cash settled share-based
compensation
14,257
17,921
Adjusted EBITDA (non-GAAP)
$
(23,149
)
$
(7,492
)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230509005905/en/
Investor Relations ir@microvast.com (346) 309-2562 Monica Gould
monica@blueshirtgroup.com (212) 871-3927
Microvast (NASDAQ:MVST)
Historical Stock Chart
From Aug 2024 to Sep 2024
Microvast (NASDAQ:MVST)
Historical Stock Chart
From Sep 2023 to Sep 2024